Calidi Biotherapeutics CLDI
NYSE CLDI
$0.64 -0.01 (-1.51%)
As of: Oct 23, 2026 · 3:13 PM EDT

Calidi Biotherapeutics (CLDI) Price to Book (2024 - 2026)

Updated

Calidi Biotherapeutics' (CLDI) Price to Book came in at 1.23 for Q2 2026, down 67.9% from 3.82 a year earlier.

Analysis

Calidi Biotherapeutics (CLDI) Price to Book (2024 - 2026) Analysis & Trends

For FY2025, Calidi Biotherapeutics' Price to Book stood at 1.34, down 71.4% from FY2024.

  • In prior years, Calidi Biotherapeutics' Price to Book was 4.68 in FY2024.
  • Quarterly Price to Book has run from a low of 1.04 in Q3 2025 to a high of 4.68 in Q4 2024 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Calidi Biotherapeutics 906,381.60 -24.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.23
Dec 31, 2025 1.34
Sep 30, 2025 1.04
Jun 30, 2025 3.82
Mar 31, 2025 2.47
Dec 31, 2024 4.68
API Access

Calidi Biotherapeutics Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=CLDI&period=max&api_key=YOUR_API_KEY